Most a short while ago, it's been identified that conolidine and the above mentioned derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to the big selection of endogenous opioids. Unlike most opioid receptors, this receptor acts for a scavenger and does not activate